ClinicalTrials.Veeva

Menu

Medication Adherence Enhancement in Heart Transplant Recipients

H

Hannover Medical School (MHH)

Status

Unknown

Conditions

Medication Adherence
Rejection
Self Management

Treatments

Behavioral: behavioral adaptation and symptom management

Study type

Interventional

Funder types

Other

Identifiers

NCT00843960
IFB-P46-377

Details and patient eligibility

About

Medication-related non-adherence increases the risk of rejections and associated graft loss after solid organ transplantation. A randomized controlled intervention will use adherence enhancing strategies out of a larger sample of 300 heart transplant recipients. Non-Adherence will be assessed by patients' self-report and based on immunosuppression level. All non-adherent patients will be randomly designed to either intervention or control group. Multi-module interventions include patient education, electronic medication event monitoring, and a combined behavior and symptom management. Longitudinal follow-up is envisioned after initial intervention.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all eligible patients with follow-up at our outpatient clinic
  • written informed consent
  • sufficient German language skills to read and answer a battery of questionnaires
  • > 18 years
  • minimum 6 mts post HTX

Exclusion criteria

  • illiteracy

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

150 participants in 2 patient groups

1
Active Comparator group
Description:
intervention group
Treatment:
Behavioral: behavioral adaptation and symptom management
2
No Intervention group
Description:
control group

Trial contacts and locations

1

Loading...

Central trial contact

Christiane Kugler, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems